Next Article in Journal
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity
Previous Article in Journal
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments
 
 
Article

Article Versions Notes

Antibodies 2024, 13(2), 33; https://doi.org/10.3390/antib13020033
Action Date Notes Link
article html file updated 25 June 2025 21:37 CEST Update https://www.mdpi.com/2073-4468/13/2/33/html
article html file updated 22 April 2024 14:08 CEST Original file -
article supplementary file uploaded. 22 April 2024 14:06 CEST - https://www.mdpi.com/2073-4468/13/2/33#supplementary
article pdf uploaded. 22 April 2024 14:06 CEST Version of Record https://www.mdpi.com/2073-4468/13/2/33/pdf
article xml uploaded. 22 April 2024 14:06 CEST Update https://www.mdpi.com/2073-4468/13/2/33/xml
article xml file uploaded 22 April 2024 14:06 CEST Original file -
Back to TopTop